SCHEMBL4859296

SCHEMBL4859296

COc1ccccc1CC[PH](=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.51
CHRM2 P08172 2/20 0.49
CHRM1 P11229 2/20 0.49
CHRM3 P20309 1/20 0.49
ABCB1 P08183 1/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
AOC3 Q16853 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA5A P35218 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
KCNH2 Q12809 2/20 0.45
HTT P42858 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HRH3 Q9Y5N1 1/20 0.44
IDO1 P14902 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22829797 0.83 L3MBTL1 (0.47) TAAR1CHRM2CHRM1ABCB1MTNR1A
SCHEMBL4925705 0.80 TAAR1 (0.51) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL10782057 0.79 TAAR1 (0.55) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL28858018 0.75 TAAR1 (0.75) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL28603322 0.75 ABCB1 (0.52) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL11487055 0.75 TAAR1 (0.53) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL8933532 0.73 LTA4H (0.50) TAAR1HTTL3MBTL1
SCHEMBL1806246 0.72 TAAR1 (0.64) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL1805222 0.72 TAAR1 (0.64) TAAR1CHRM2CHRM1CHRM3ABCB1
SCHEMBL7831226 0.72 TAAR1 (0.69) TAAR1CHRM2CHRM1ABCB1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8471067-B2 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile UNIVERSITY COLLEGE DUBLIN (IE) 2013-06-25 US claimed
US-20080255391-A1 Chiral Phosphorus Compounds UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND (IE) 2008-10-16 US claimed
JP-2008501010-A 2008-01-17 JP claimed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 EP claimed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 WO claimed
US-20200407381-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS Université de Bourgogne (FR) 2020-12-31 US disclosed
CN-111868065-A C-sterically hindered P-chirally derived organophosphorus compounds 勃艮第大学 2020-10-30 CN disclosed
US-8471067-B2 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile UNIVERSITY COLLEGE DUBLIN (IE) 2013-06-25 US disclosed
WO-2012113889-A1 PROCESSES FOR THE STEREOSELECTIVE PREPARATION OF P-CHIRAL FOUR -COORDINATED PHOSPHORUS BORANE COMPOUNDS AND P-CHIRAL THREE-COORDINATED PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2012-08-30 WO disclosed
US-20080255391-A1 Chiral Phosphorus Compounds UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND (IE) 2008-10-16 US disclosed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 EP disclosed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 WO disclosed
US-4220590-A OPTICALLY ACTIVE BIS PHOSPHINE COMPOUNDS MONSANTO COMPANY (US) 1980-09-02 US disclosed
US-4142992-A ASYMMETRIC CATALYSIS MONSANTO COMPANY (US) 1979-03-06 US disclosed
US-4008281-A BIS-PHOSPHINE MONSANTO COMPANY (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407381-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS PLCG1, PLCG2, ACHE TAAR1 4016/4885CHRM2 825/4885CHRM1 792/4885
US-20080255391-A1 Chiral Phosphorus Compounds PHOSPHO1, PNKP, PTMS TAAR1 495/4885CHRM2 3708/4885CHRM1 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.